Matching film-coated placebo tablet

DRUG2 trials

Sponsors

Bioprojet Pharma

Conditions

Binge eating disorderObsessive compulsive disorder

Phase 2

A double-blind, placebo-controlled pilot trial of BP1.4979 for the treatment of binge eating disorder.

CompletedCTIS2023-506511-17-00

Bioprojet PharmaBinge eating disorder

Start: 2022-03-07End: 2025-11-24Target: 86Updated: 2025-05-14

A multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 2a trial to evaluate the efficacy and safety of BP1.4979 in adult participants with obsessive compulsive disorder

RecruitingCTIS2025-522026-13-00

Bioprojet PharmaObsessive compulsive disorder

Start: 2026-01-12Target: 54Updated: 2026-01-21